Perspective Therapeutics (CATX) Receivables (2011 - 2026)

Perspective Therapeutics has disclosed Receivables across 16 years of filings, most recently posting $269000.0 for Q2 2026.

• In Q2 2026, Receivables rose 19.56% year-over-year to $269000.0; the TTM figure through Jun 2026 stood at $269000.0 (up 19.56% YoY), while the FY2025 annual figure was $16000.0, down 97.35% from the prior year.
• Receivables came in at $269000.0 for Q2 2026 at Perspective Therapeutics, up from $58000.0 in the prior quarter.
• In the past five years, Receivables ranged from a high of $2.1 million in Q1 2022 to a low of $16000.0 in Q4 2025.
• Average Receivables over 5 years is $806222.2, with a median of $801000.0 recorded in 2024.
• The largest YoY upside for Receivables was 58.45% in 2025 against a maximum downside of 97.35% in 2025.
• Over 5 years, Receivables stood at $1.4 million in 2022, then dropped by 13.92% to $1.2 million in 2023, then slumped by 48.68% to $603000.0 in 2024, then plunged by 97.35% to $16000.0 in 2025, then soared by 1581.25% to $269000.0 in 2026.
• Per Business Quant data, the three most recent Receivables figures were $269000.0 in Q2 2026, $58000.0 in Q1 2026, and $16000.0 in Q4 2025.